Dulaglutide vs Ecnoglutide

Dulaglutide (brand name Trulicity) is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes and reduce cardiovascular risk, while ecnoglutide is a GLP-1 receptor agonist still in development (pipeline) with no approved treatments yet. Both work similarly by mimicking a gut hormone to help control blood sugar, but dulaglutide is already available as a once-weekly injection, whereas ecnoglutide’s form and dosing are not yet finalized.

AI summary of the sources below.